Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tanguy Seiwert
University of Chicago Comprehensive Cancer Center P2C
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chinese University of Hong Kong-Prince of Wales Hospital
Shatin, Hong Kong, China
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Central Illinois Hematology Oncology Center
Springfield, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Mercy Hospital Saint Louis
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2010
- Primary completion
- 31 Dec 2013
- Completion
- 31 Dec 2013
- Last update posted
- 27 Mar 2017
- Registered enrollment
- 86
- Registry id
- NCT01256385
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.